Metformin and Cancer: Is This the End?

Endocr Pract. 2022 Aug;28(8):832-834. doi: 10.1016/j.eprac.2022.06.005. Epub 2022 Jun 18.
No abstract available

Keywords: MA.32; breast cancer; insulin resistance; metformin.

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms*
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Insulin
  • Insulin Resistance*
  • Metformin* / therapeutic use
  • Neoplasms* / drug therapy

Substances

  • Hypoglycemic Agents
  • Insulin
  • Metformin